Fulgent Genetics, Inc.
FLGT
$18.82
-$0.74-3.78%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.92% | 8.10% | -15.28% | 4.68% | -2.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.92% | 8.10% | -15.28% | 4.68% | -2.54% |
| Cost of Revenue | 6.46% | -2.01% | 0.29% | -5.80% | -10.51% |
| Gross Profit | 28.24% | 26.24% | -32.81% | 28.77% | 17.51% |
| SG&A Expenses | 10.76% | -19.73% | 8.73% | 4.20% | -4.41% |
| Depreciation & Amortization | 0.00% | 1.74% | 1.84% | 1.43% | 1.12% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.08% | -8.92% | 5.15% | 2.60% | -5.18% |
| Operating Income | 9.19% | 47.76% | -8,080.84% | 4.51% | 12.19% |
| Income Before Tax | 17.29% | 94.46% | -370.15% | 23.71% | 32.67% |
| Income Tax Expenses | 153.82% | 82.92% | -118.88% | 31.70% | 93.71% |
| Earnings from Continuing Operations | 14.06% | 95.39% | -9.12% | 21.57% | 12.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.91% | -95.12% | -87.19% | 5.26% | -24.56% |
| Net Income | 14.35% | 95.41% | -11.76% | 22.43% | 12.24% |
| EBIT | 9.19% | 47.76% | -8,080.84% | 4.51% | 12.19% |
| EBITDA | 8.32% | 59.17% | -268.23% | 5.44% | 15.66% |
| EPS Basic | 17.29% | 95.54% | -10.28% | 23.15% | 12.94% |
| Normalized Basic EPS | 20.72% | 51.25% | -211.30% | 25.63% | 33.51% |
| EPS Diluted | 17.29% | 95.52% | -9.45% | 23.68% | 13.04% |
| Normalized Diluted EPS | 20.72% | 51.25% | -211.30% | 25.63% | 33.51% |
| Average Basic Shares Outstanding | 3.57% | 2.96% | 1.34% | 0.96% | 0.79% |
| Average Diluted Shares Outstanding | 3.57% | 2.96% | 1.34% | 0.96% | 0.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |